Theophylline sodium acetate
Cat. No.: IBDI-432759
Theophylline (1,3-Dimethylxanthine) sodium acetate is a potent phosphodiesterase (PDE) inhibitor, adenosine receptor antagonist, and histone deacetylase (HDAC) activator. Theophylline (1,3-Dimethylxanthine) sodium acetate inhibits PDE3 activity to relax airway smooth muscle. Theophylline (1,3-Dimethylxanthine) sodium acetate has anti-inflammatory activity by increase IL-10 and inhibit NF-κB into the nucleus. Theophylline (1,3-Dimethylxanthine) sodium acetate induces apoptosis. Theophylline (1,3-Dimethylxanthine) sodium acetate can be used for asthma and chronic obstructive pulmonary disease (COPD) research.
Product Details
Target |
Endogenous Metabolite | PhosphodiesteRase (PDE) | Adenosine Receptor | HDAC | Apoptosis | Interleukin Related | TNF Receptor |
Molecular Weight |
284.18 |
Synonyms |
1,3-Dimethylxanthine sodium acetate, Theo-24 sodium acetate |
SMILES |
CC(O[Na])=O.O=C(N1C)N(C)C2=C([N-]C=N2)C1=O.[Na+] |
Storage & Handling
Shipping |
Room temperature in continental US. May vary elsewhere. |
Storage |
Please store the product under the recommended conditions in the Certificate of Analysis. |
Regulatory Status |
This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. |
! For research use only, not intended for any clinical use.